Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART

Clin Dev Immunol. 2011:2011:239021. doi: 10.1155/2011/239021. Epub 2010 Dec 1.

Abstract

Background & objective: IRIS is an important complication that occurs during management of HIV-TB coinfection and it poses difficulty in diagnosis. Previous studies have reported variable incidence of IRIS. The present study was undertaken to describe the pattern of TB-associated IRIS using recently proposed consensus case-definitions for TB-IRIS for its use in resource-limited settings.

Methods: A prospective analysis of ART-naïve adults started on HAART from November, 2008 to May, 2010 was done in a tertiary care hospital in north India. A total 224 patients divided into two groups, one with HIV-TB and the other with HIV alone, were followedup for a minimum period of 3 months. The diagnosis of TB was categorised as ''definitive" and ''probable".

Results: Out of a total of 224 patients, 203 completed followup. Paradoxical TB-IRIS occurred in 5 of 123 (4%) HIV-TB patients while 6 of 80 (7.5%) HIV patients developed ART-associated TB. A reduction in plasma viral load was significantly (P = .016) associated with paradoxical TB-IRIS. No identifiable risk factors were associated with the development of ART-associated TB.

Conclusion: The consensus case-definitions are useful tools in the diagnosis of TB-associated IRIS. High index of clinical suspicion is required for an early diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology
  • AIDS-Related Opportunistic Infections / immunology
  • Acquired Immunodeficiency Syndrome* / complications
  • Acquired Immunodeficiency Syndrome* / drug therapy
  • Acquired Immunodeficiency Syndrome* / immunology
  • Adult
  • Anti-HIV Agents* / adverse effects
  • Anti-HIV Agents* / therapeutic use
  • Antiretroviral Therapy, Highly Active* / adverse effects
  • Antitubercular Agents / therapeutic use
  • Biomarkers / analysis
  • Female
  • HIV Seropositivity / complications
  • HIV Seropositivity / drug therapy
  • HIV*
  • Humans
  • Immune Reconstitution Inflammatory Syndrome* / drug therapy
  • Immune Reconstitution Inflammatory Syndrome* / etiology
  • Immune Reconstitution Inflammatory Syndrome* / physiopathology
  • India
  • Male
  • Prospective Studies
  • Risk Factors
  • Tuberculosis / complications
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology
  • Viral Load

Substances

  • Anti-HIV Agents
  • Antitubercular Agents
  • Biomarkers